Comparative Benchmarking
In the context of the broader market, CLDI competes directly with industry leaders such as MTVA and PHGE. With a market capitalization of $6.18M, it holds a leading position in the sector. When comparing efficiency, CLDI's gross margin of N/A stands against MTVA's N/A and PHGE's N/A. Such benchmarking helps identify whether Calidi Biotherapeutics Inc is trading at a premium or discount relative to its financial performance.
